Northern Trust’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.1K | Hold |
15,431
| – | – | ﹤0.01% | 4313 |
|
|
2025
Q4 | $29.8K | Buy |
15,431
+461
| +3% | +$920 | ﹤0.01% | 4354 |
|
|
2025
Q3 | $31.4K | Hold |
14,970
| – | – | ﹤0.01% | 4335 |
|
|
2025
Q2 | $35.8K | Sell |
14,970
-74
| -0.5% | -$216 | ﹤0.01% | 4283 |
|
|
2025
Q1 | $43.5K | Buy |
15,044
+74
| +0.5% | +$230 | ﹤0.01% | 4245 |
|
|
2024
Q4 | $46.7K | Sell |
14,970
-489
| -3% | -$1.7K | ﹤0.01% | 4263 |
|
|
2024
Q3 | $50.1K | Buy |
15,459
+2
| +0% | +$7 | ﹤0.01% | 4210 |
|
|
2024
Q2 | $62.3K | Buy |
15,457
+182
| +1% | +$882 | ﹤0.01% | 4168 |
|
|
2024
Q1 | $89.9K | Hold |
15,275
| – | – | ﹤0.01% | 4108 |
|
|
2023
Q4 | $56.6K | Buy |
15,275
+1,832
| +14% | +$8.37K | ﹤0.01% | 4218 |
|
|
2023
Q3 | $74.5K | Hold |
13,443
| – | – | ﹤0.01% | 4076 |
|
|
2023
Q2 | $147K | Sell |
13,443
-29
| -0.2% | -$344 | ﹤0.01% | 3934 |
|
|
2023
Q1 | $168K | Hold |
13,472
| – | – | ﹤0.01% | 3919 |
|
|
2022
Q4 | $134K | Hold |
13,472
| – | – | ﹤0.01% | 4004 |
|
|
2022
Q3 | $162K | Hold |
13,472
| – | – | ﹤0.01% | 3958 |
|
|
2022
Q2 | $199K | Buy |
13,472
+1,728
| +15% | +$26K | ﹤0.01% | 3926 |
|
|
2022
Q1 | $210K | Buy |
11,744
+29
| +0.2% | +$548 | ﹤0.01% | 4114 |
|
|
2021
Q4 | $281K | Buy |
11,715
+5,799
| +98% | +$119K | ﹤0.01% | 4050 |
|
|
2021
Q3 | $119K | Buy |
5,916
+706
| +14% | +$13.9K | ﹤0.01% | 4357 |
|
|
2021
Q2 | $118K | Hold |
5,210
| – | – | ﹤0.01% | 4324 |
|
|
2021
Q1 | $106K | Buy |
5,210
+29
| +0.6% | +$707 | ﹤0.01% | 4273 |
|
|
2020
Q4 | $83K | Buy |
5,181
+179
| +4% | +$2.51K | ﹤0.01% | 4149 |
|
|
2020
Q3 | $60K | Buy |
5,002
+791
| +19% | +$10.5K | ﹤0.01% | 4079 |
|
|
2020
Q2 | $50K | Buy |
4,211
+2,547
| +153% | +$31.2K | ﹤0.01% | 4057 |
|
|
2020
Q1 | $17K | Buy |
1,664
+792
| +91% | +$10.7K | ﹤0.01% | 4103 |
|
|
2019
Q4 | $9K | Hold |
872
| – | – | ﹤0.01% | 4201 |
|
|
2019
Q3 | $8K | Hold |
872
| – | – | ﹤0.01% | 4197 |
|
|
2019
Q2 | $9K | Hold |
872
| – | – | ﹤0.01% | 4210 |
|
|
2019
Q1 | $15K | Hold |
872
| – | – | ﹤0.01% | 4149 |
|
|
2018
Q4 | $7K | Hold |
872
| – | – | ﹤0.01% | 4220 |
|
|
2018
Q3 | $10K | Hold |
872
| – | – | ﹤0.01% | 4255 |
|
|
2018
Q2 | $12K | Buy |
+872
| New | +$11.6K | ﹤0.01% | 4242 |
|
|
2017
Q3 | – | Sell |
-185
| Closed | -$10K | – | 4262 |
|
|
2017
Q2 | $10K | Hold |
185
| – | – | ﹤0.01% | 4221 |
|
|
2017
Q1 | $18K | Buy |
185
+76
| +70% | +$11K | ﹤0.01% | 4161 |
|
|
2016
Q4 | $9K | Buy |
109
+5
| +5% | +$476 | ﹤0.01% | 4136 |
|
|
2016
Q3 | $13K | Hold |
104
| – | – | ﹤0.01% | 4124 |
|
|
2016
Q2 | $27K | Hold |
104
| – | – | ﹤0.01% | 4089 |
|
|
2016
Q1 | $34K | Buy |
+104
| New | +$29.3K | ﹤0.01% | 4073 |
|
Other funds holding DARE
VCM
VFT
XT
Northern Trust's DARE Position: Q1 2026 in Review
Northern Trust held its Dare Bioscience (DARE) position steady in Q1 2026 at 15,431 shares worth $28.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4313.
Northern Trust first reported a position in DARE in Q1 2016 and has held it in 38 quarters since. The position peaked at $281K in Q4 2021. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.
- Northern Trust held 15,431 shares of Dare Bioscience worth $28.1K as of Q1 2026.
- Northern Trust left its Dare Bioscience share count unchanged in Q1 2026.
- Dare Bioscience made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4313 holding.
- Northern Trust first reported a position in Dare Bioscience in Q1 2016 and has held it in 38 quarters since.
- Northern Trust's Dare Bioscience position peaked at $281K in Q4 2021.
- 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.